Investor Relations

LifeMD, Inc. (NASDAQ: LFMD) is a leading telehealth company that is transforming the healthcare landscape with direct-to-patient product and service offerings. LifeMD's telemedicine platform enables virtual access to affordable and convenient medical treatment from licensed providers and, when appropriate, prescription medications and over-the-counter products delivered directly to the patient's home.

Investor Documents

Open Letter to Shareholders

April 16, 2021

Investor Presentation

See our latest corporate presentation.

2020 Annual Filing

See our latest annual filing.


Past Events

33rd Annual ROTH Growth Conference
March 15-17, 2021
Learn More
Fourth Quarter and Full Year 2020 Conference Call
March 29, 2021 at 4:30 p.m
Learn More

Receive automated Investor Alerts directly to your inbox

Stock Information

SEC Filings

{{ `${sec.title}` }}

{{ sec.description }}

View All Filings

Frequently Asked Questions

Our stock is traded on the NASDAQ under the symbol LFMD.
LifeMD is incorporated in the State of Delaware in the U.S.
800 Third Avenue
Suite 2800
New York, New York
The last day of our fiscal year is December 31. Our fiscal quarters end on March 31, June 30, September 30, and December 31.
Worldwide Stock Transfer
1 University Plaza
Suite 505
Hackensack, NJ 07601
Friedman, LLP
One Liberty Plaza
165 Broadway, Floor 21
New York, NY 10006
Lucosky Brookman LLPOTCQX Sponsor
101 Wood Avenue South
5th Floor
Woodbridge, NJ 08830
Ashley Robinson
LifeSci Advisors, LLC
[email protected]

Investor Contact Information

Company/Investor Relations

Marc Benathen, CFO
Email Contact

Transfer Agent

Worldwide Stock Transfer, LLC
One University Plaza, Suite 505
Hackensack, NJ 07601